SIRT1 and colorectal carcinoma: In the NFYB/ E2F1/CHK1 axis, SIRT1 can deacetylate E2F1 to inhibit its pro apoptotic activity, which is essential for maintaining oxaliplatin resistance in OR-CRC cells (Fang et al., 2018).